Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
-
Polona Žigon
,
Aleš Ambrožič
Abstract
Background: Two approaches for detecting anti-prothrombin antibodies have been described. The first detects antibodies against prothrombin alone and the second, phos-phatidylserine-dependent antiprothrombin antibodies. The latter more often correlate with clinical manifestations of antiphospholipid syndrome and with lupus anticoagulant activity.
Methods: In order to increase the capacity of antibody binding, we modified the previously described phosphatidylser-ine-dependent antiprothrombin ELISA and determined their avidity. We examined 203 patients with systemic autoimmune diseases and 222 blood donors.
Results: Our modification resulted in a greater intensity of antibody binding to prothrombin on phosphatidylserine-coated plate surfaces compared to the previously described method. By changing ELISA conditions, we were able to detect with one assay the two, presumably different, populations of antiprothrombin antibodies. Diagnostic specificities of both ELISAs for antiphospholipid syndrome were similar (92.5% vs. 93.1%), while the sensitivity of the modified phosphatidylserine-dependent antiprothrombin ELISA was significantly higher than the anti-prothrombin alone ELISA (59% vs. 25%). Low avidity antiprothrombin antibodies were only detected in the modified phosphatidylserine-dependent antiprothrombin ELISA. Four percent of patients with positive phosphatidylserine-dependent antiprothrombin antibodies, showing clinical manifestations of antiphospholipid syndrome, were negative for all other antiphospholipid antibodies. The risk for antiphospholipid syndrome increased with the number of antiphospholipid antibody positivity.
Conclusions: We conclude that antibodies detected with a modified phosphatidylserine-dependent antiprothrombin ELISA could improve the diagnosis of antiphospholipid syndrome by offering additional information on the risk for thrombosis, especially in patients negative for other antiphospholipid antibodies.
©2011 by Walter de Gruyter Berlin Boston
Artikel in diesem Heft
- Editors’ and Publisher’s Note
- CCLM Award for The Most Cited Paper Recently Published
- Reviews
- Some views on proteomics in diabetes
- Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics
- Minireviews
- Low-density lipoprotein receptor-related protein 1: new functions for an old molecule
- Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
- Opinion Paper
- Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization
- General Clinical Chemistry and Laboratory Medicine
- Use of a fully automated immunoassay for celiac disease screening in a pediatric population
- Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure
- Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
- Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia
- The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study
- Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
- Perchlorate (Irenat®) may falsely lower measured ionised calcium
- Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
- A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
- Reference Values and Biological Variations
- Reference change values for monitoring dehydration
- Cancer Diagnostics
- Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis
- Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study
- Cardiovascular Diseases
- High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
- Letters to the Editor
- Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes
- Trueness assessment of Korean nation-wide glucose proficiency testing
- Genetic polymorphism of cytochrome P450 1A1 in a northern Italian population: high frequency of the CYP1A1*2C allele
- Prestaining of PCR products with SYBR Green for agarose gel electrophoresis: advantages and limitations
- A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells
- Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial
- Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method
- Cross-reactivity of insulin analogs with the Diasorin Liaison Insulin assay
- Improved turnaround time for neonatal hematology profile tests (complete blood count) using a new microcollection tube
- Erratum
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Artikel in diesem Heft
- Editors’ and Publisher’s Note
- CCLM Award for The Most Cited Paper Recently Published
- Reviews
- Some views on proteomics in diabetes
- Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics
- Minireviews
- Low-density lipoprotein receptor-related protein 1: new functions for an old molecule
- Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
- Opinion Paper
- Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization
- General Clinical Chemistry and Laboratory Medicine
- Use of a fully automated immunoassay for celiac disease screening in a pediatric population
- Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure
- Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
- Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia
- The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study
- Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
- Perchlorate (Irenat®) may falsely lower measured ionised calcium
- Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
- A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
- Reference Values and Biological Variations
- Reference change values for monitoring dehydration
- Cancer Diagnostics
- Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis
- Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study
- Cardiovascular Diseases
- High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
- Letters to the Editor
- Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes
- Trueness assessment of Korean nation-wide glucose proficiency testing
- Genetic polymorphism of cytochrome P450 1A1 in a northern Italian population: high frequency of the CYP1A1*2C allele
- Prestaining of PCR products with SYBR Green for agarose gel electrophoresis: advantages and limitations
- A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells
- Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial
- Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method
- Cross-reactivity of insulin analogs with the Diasorin Liaison Insulin assay
- Improved turnaround time for neonatal hematology profile tests (complete blood count) using a new microcollection tube
- Erratum
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
